Alcohol on a GLP-1: calories, nausea, glucose and the label warnings that touch it

Neither the Wegovy nor the Zepbound label lists an interaction with alcohol. That does not make it a neutral question. Alcohol touches four things the medication is already acting on: energy intake, the stomach, blood glucose and the pancreas.

The energy arithmetic

Ethanol carries about 7 kcal per gram. A standard drink in the United States contains about 14 g of pure alcohol (NIAAA), so the alcohol alone is roughly 98 kcal, before the carbohydrate in beer, the sugar in wine and cocktails, or the mixer. A 150 ml glass of wine lands around 120 to 130 kcal; a pint of 5 percent beer around 200 to 240; a sugary cocktail can pass 300. Those are liquid calories that do not register as food, do not carry protein or fibre, and on an intake of 1,400 kcal a day are a large fraction of it.

Alcohol also lowers inhibition around food. The advisory's wider point about liquid calories and grazing applies twice over in the evening.

Why the advisory says to minimise it

The 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society states that alcohol may worsen nausea and gastro-oesophageal reflux with GLP-1 therapy and should be minimised (PubMed 40445127). The mechanism is straightforward: alcohol irritates the gastric lining and relaxes the lower oesophageal sphincter, and the drug has slowed gastric emptying, so a stomach that holds food longer now also holds alcohol longer. Many people notice they feel the effect of a drink faster and for longer on therapy. Treat that as a reason to drink less, not a benefit.

Glucose: the warning that matters if you take other medications

The Wegovy and Zepbound labels warn of hypoglycaemia when the drug is used with insulin or an insulin secretagogue such as a sulfonylurea, and advise considering a reduction of those medications (a prescriber's decision). Alcohol independently lowers blood glucose by suppressing hepatic glucose output, and the American Diabetes Association's standards note that alcohol raises the risk of delayed hypoglycaemia in people using insulin or secretagogues, particularly when consumed without food. Stack the three and an evening of drinking on an empty, slow stomach becomes a hypoglycaemia risk hours later. If you take insulin or a sulfonylurea with a GLP-1, discuss alcohol with your prescriber specifically, eat when you drink, and know the symptoms.

Pancreatitis and liver

Both labels carry a warning for acute pancreatitis and advise stopping the drug if it is suspected. Heavy alcohol use is one of the two commonest causes of pancreatitis in adults. The label does not say alcohol increases the drug's risk; it is simply that two independent risk factors for the same serious condition are a poor combination, and that severe persistent abdominal pain after drinking on a GLP-1 needs assessment rather than assumptions. Alcohol's effects on the liver are additive to those of obesity, and improving liver fat is one of the reasons many people are prescribed these drugs in the first place.

Sleep and the scale

Alcohol fragments sleep in the second half of the night, and short or broken sleep raises intake and shifts weight loss away from fat (see sleep). It also holds water the next day and then sheds it, which is one of the commoner reasons a weekly weigh-in lies (see how to weigh yourself). If a stall coincides with a heavier drinking stretch, that is the first variable to change (see plateaus).

A workable position

• The Dietary Guidelines for Americans cap is up to two drinks a day for men and one for women on days alcohol is consumed, and less is better for health. On a GLP-1, the advisory's word is minimise.
• If you drink, eat protein first and drink after, not on an empty stomach; keep the drink small; and stop at one, because the second arrives on a stomach still processing the first.
• Do not drink on an escalation week, when nausea is already most likely.
• If you take insulin or a sulfonylurea, ask your prescriber before deciding anything about alcohol.
• If you notice that your desire for alcohol has fallen on therapy, which some people report, there is no reason to override it.

Compounded GLP-1 products, if that is what you take, are not FDA approved and not interchangeable with the brand products whose labels are cited here; the physiology above does not depend on the product, but tell your prescriber exactly what you take.